Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-017556

SVP, Controller and PAO sold 732 shares at $138.17 ($101,140)

  • SVP, Controller and PAO acquired 1,560 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Huizenga Theodore Alan · SVP, Controller and PAO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-01 Grant or award : show line 1 in the form +1,560 17,276 D
2021-03-01 Sale : show line 2 in the form −732 $138.17 $101,140 16,544 D
Open-market sales · 732 sh · avg $138.17 · $101,140

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-01 Grant or award : show line 3 in the form Stock Option (Right to Buy) +4,655 4,655 D
Loading xslF345X03/doc4.xml…